Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 5 Breast Neoplasms 4 Ovarian Neoplasms 3 Triple Negative Breast Neoplasms 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Overweight 2 Obesity 2 Multiple Myeloma 2 Motor Activity 2 Melanoma 2 Lung Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Weight Loss 1 Uveal Melanoma 1 Smoking Cessation 1 Quality of Life 1 Postoperative Complications 1 Patient Compliance 1 Neoplasms 1 Metabolic Syndrome 1 Localized Prostate Carcinoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Insulin Resistance 1 Inflammation 1 Hypothalamic Neoplasms 1 Healthy Diet 1 Glioma 1 Gastrointestinal Neoplasms 1

Interventions

regorafenib 1 beta-Aminoethyl Isothiourea 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Self Care 1 Ocoxin 1 Nutrition Assessment 1 Motivational Interviewing 1 Leuprolide 1 Goserelin 1 Diet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Compliance × Diet Therapy × 1 year × Clear all

NCT06635005 2026-05-11

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Completed

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡